Inhalation

Unparalleled Expertise and Transparency Drive a Unique Development, Manufacturing, and Clinical Supply Experience

David Wood

Experic

Complex Injectables

Bringing Complex Injectable Products to Market with Greater Efficiency

James He

ForDoz Pharma

Formulation

Overcoming Challenges to High-Concentration Formulation Development

Heonchang Lim

Samsung Biologics

Lyophilization

Ensuring Biologic Stability with Tailored and Cutting-Edge Lyophilization Solutions

Brecht Vanbillemont, Dr.; Lisa Besslich, Dr. Rer. Nat.

Coriolis Pharma

Developability

Streamlining Drug Development with Integrated In Silico and Laboratory Developability Assessments

Andrea Arsiccio, Ph.D.,; Eva Keilhauer, Ph.D.; Kristian Le Vay, Ph.D.

Coriolis Pharma

Particle ID

Leveraging Formulation Development Experience for Effective Particle Identification

Jörg Müller, Ph.D.

Coriolis Pharma

Minitablets

Minitablets: Enhancing Safety and Palatability for Pediatric Medicines

Gus LaBella

Mikart

Drug Delivery

Nanocarriers to Overcome the Blood–Brain Barrier (BBB)

Serene Lee

Nice Insight

Developability

Assessing Developability and Designing Advanceable Formulations from the Start

Nazar Elkarim, Ph.D.

Mikart

Developability

Streamlining the Path to Approval with Developability and Pre-Formulation Platforms

Andrea Hawe

Coriolis Pharma

CRDO

Partnering with Scientific Excellence to De-Risk and Accelerate Drug Development

Silvia Steyrer-Gruber

Coriolis Pharma

Liquid Suspensions

Beyond Pills: the Rise of Liquid Suspensions for Complex Formulations

Gus LaBella

Mikart

Lipid Nanoparticles

Feasibility Studies and cGMP Design Supporting Continuous Lipid Nanoparticle Manufacturing

Jim Ziogas

DIANT Pharma

mRNA Innovations

Technology Advances Needed to Drive Future mRNA Growth

Hagen Richter, Ph.D.

mRNA–LNP Manufacturing

The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles

Antonio Costa, Ph.D.; William Pasek

DIANT Pharma

Advanceability

Right from the Start: Designing Advanceable Formulations and Processes at Phase I

Serán Bioscience

Biologics Formulation

Successful Formulation Development for Biologics Using a Unique Biophysical Prediction and Screening Platform

Pawel Stanczak, Ph.D.

Tanvex CDMO

CDMO

Maximizing Outsourcing Benefits for Virtual Pharma Companies

William Kazimier

Tedor Pharma Services

Lipid Nanoparticles

Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform

Antonio Costa, Ph.D.

DIANT Pharma